Why is Thyrocare Tech. falling/rising?

As of 12-Aug, Thyrocare Technologies Ltd is experiencing a price increase, currently at Rs 1,350.00, reflecting a rise of 28.5 points or 2.16%. The stock has shown strong performance today, outperforming its sector by 1.32% and is close to its 52-week high, being only 1.96% away from Rs 1,376.4. Additionally, the stock has gained after three consecutive days of decline, reaching an intraday high of Rs 1,366. Thyrocare is trading above all its moving averages, indicating a positive trend, and there has been a notable increase in investor participation, with delivery volume rising by 7.17% compared to the five-day average. The company has demonstrated high management efficiency with a return on equity (ROE) of 20.45% and has reported significant growth in net profit and sales, which has contributed to its strong performance over the past year, generating a return of 61.64%.
In the broader market context, Thyrocare's short-term return of 2.36% over the past week stands in stark contrast to the Sensex, which has declined by 0.59%. This indicates that Thyrocare is not only performing well on its own but is also resilient compared to the overall market. While the stock has shown impressive growth, it does face risks such as a high valuation relative to its peers and the fact that 100% of promoter shares are pledged, which could exert downward pressure in a falling market. Nonetheless, the company's consistent positive results over the last six quarters and its ranking among the top companies by MarketsMojo suggest a strong underlying performance that supports its rising stock price.